Literature DB >> 692178

Alteration of the activity and molecular from of thymidine kinase during development and aging in the mouse cerebellum.

P C Caron, B R Unsworth.   

Abstract

Protein, DNA and thymidine kinase levels were assayed during development and aging in the mouse cerebellum. A roughly parallel increase in protein and DNA content occurred from birth, reaching a plateau at 18 days; these adult levels increased by 30% in the 23 month-old cerebellum. Thymidine kinase activity reached a maximum at 6 postnatal days, then decreased steadily to reach, at 18 days, the low level that was maintained in the adult. The thymidine kinase synthesized in the aged cerebellum differed from that in the neonate by having (i) an increased specific activity, (ii) a faster migrating species upon electrophoresis, (iii) an inhibition by dCTP, and (iv) a lower affinity for the substrate thymidine (higher Km). Mathematical calculations indicated the appearance of a larger number of smaller sized cells in the aged cerebellum, when compared with the young adult. Histological analysis established that the newly synthesized cells were localized in the molecular layer of the old cerebellum. It appears that senescence in the mouse cerebellum may be associated with an increased synthesis of glial cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692178     DOI: 10.1016/0047-6374(78)90017-9

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  5 in total

1.  Postnatal ontogeny of uridine kinase in the cerebellum, hypothalamus, and cerebral cortex of the rat.

Authors:  M Litteria; C G Popoff
Journal:  Neurochem Res       Date:  1985-01       Impact factor: 3.996

2.  Serum thymidine kinase levels in cancer patients.

Authors:  K L O'Neill; W P Abram; P G McKenna
Journal:  Ir J Med Sci       Date:  1986-08       Impact factor: 1.568

3.  Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes.

Authors:  B Munch-Petersen
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

4.  Thymidine kinase isoenzymes in human acute monocytic leukemia.

Authors:  B Munch-Petersen; G Tyrsted
Journal:  Mol Cell Biochem       Date:  1985-03       Impact factor: 3.396

5.  Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.

Authors:  P G McKenna; K L O'Neill; W P Abram; B M Hannigan
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.